NasdaqCM - Delayed Quote USD

CalciMedica, Inc. (CALC)

1.7400
+0.0601
+(3.58%)
At close: June 6 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
24,934
24,204
38,075
14,193
34,595
Operating Income
-24,934
-24,204
-38,075
-14,193
-34,595
Net Non Operating Interest Income Expense
--
--
-110
-132
126
Other Income Expense
6,509
10,504
3,718
6,501
-1,352
Pretax Income
-18,872
-13,700
-34,357
-7,824
-35,821
Net Income Common Stockholders
-18,872
-13,700
-34,357
-9,142
-35,821
Diluted NI Available to Com Stockholders
-18,872
-13,700
-34,357
-9,142
-35,821
Basic EPS
-1.59
--
-7.66
-111.16
-23.66
Diluted EPS
-1.59
--
-7.66
-111.16
-23.66
Basic Average Shares
12,337.6780
--
4,486.2580
82.2450
1,514.2350
Diluted Average Shares
12,337.6780
--
4,486.2580
82.2450
1,514.2350
Total Operating Income as Reported
-24,934
-24,204
-38,075
-14,193
-35,947
Total Expenses
24,934
24,204
38,075
14,193
34,595
Net Income from Continuing & Discontinued Operation
-18,872
-13,700
-34,357
-7,824
-35,821
Normalized Income
-24,472
-23,190
-37,525
-14,353
-34,469
Interest Income
--
--
--
575
126
Interest Expense
--
--
110
132
--
Net Interest Income
--
--
-110
-132
126
EBIT
-28,929
-24,204
-38,075
-7,692
-34,595
EBITDA
-28,871
-24,146
-38,017
-7,640
-34,076
Reconciled Depreciation
58
58
58
52
519
Net Income from Continuing Operation Net Minority Interest
-18,872
-13,700
-34,357
-7,824
-35,821
Total Unusual Items Excluding Goodwill
5,600
9,490
3,168
6,529
-1,352
Total Unusual Items
5,600
9,490
3,168
6,529
-1,352
Normalized EBITDA
-34,471
-33,636
-41,185
-14,169
-32,724
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APRE Aprea Therapeutics, Inc.
1.7500
-3.31%
 
SPRB Spruce Biosciences, Inc.
0.0639
-1.69%
 
ANTX AN2 Therapeutics, Inc.
1.1300
+1.80%
 
SCPH scPharmaceuticals Inc.
4.2000
+2.19%
 
ERGO Entia Biosciences, Inc.
0.0001
0.00%
 
XBIO Xenetic Biosciences, Inc.
2.9565
-6.28%
 
SABS SAB Biotherapeutics, Inc.
1.8100
-1.36%
 
ELAB PMGC Holdings Inc.
2.1700
+0.93%
 
XTLB XTL Biopharmaceuticals Ltd.
1.1000
-5.17%
 
BRNS Barinthus Biotherapeutics plc
0.9950
+0.51%